Drug · DIN 02455897
APO-CABERGOLINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 1, 2021; first marketed March 23, 2017.
- Drug Identification Number (DIN)
- 02455897
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Cabergoline G02CB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CABERGOLINE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 17, 2016: NOC 18187Abbreviated New Drug Submission (ANDS)